A number of recent peer-reviewed articles pertinent to CT lung cancer screening (LCS) contain substantial methodological flaws that contribute to the propagation of misinformation. Herein we highlight three important examples of misinformation regarding LCS: (1) the overestimation of downstream imaging and procedural complications after LCS, (2) the misrepresentation of LCS false-positive rate (FPR), and (3) the flawed analysis of oncogenic risk associated with radiation from CT scans.